<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7326458\results\search\drug\results.xml">
  <result pre="the initialy planned duration in four patients, two because of" exact="alanine" post="aminotransferase elevations (3 to 5 normal range) and two"/>
  <result pre="therapeutic agents for SARS-CoV-2, with controversial results. These agents include" exact="ribavirin" post="and interferon alpha 2b (IFNÎ±-2b) (Martinez, 2020), lopinavir/ritonavir (Chu"/>
  <result pre="SARS-CoV-2, with controversial results. These agents include ribavirin and interferon" exact="alpha" post="2b (IFNÎ±-2b) (Martinez, 2020), lopinavir/ritonavir (Chu et al., 2004,"/>
  <result pre="lopinavir/ritonavir (Chu et al., 2004, Arabi et al., 2020), and" exact="hydroxychloroquine" post="(Savarino et al., 2006, Chen et al., 2020, Gautret"/>
  <result pre="of illness) and was stopped on day 15, due to" exact="alanine" post="aminotransferase (ALT) elevation (195 IU/l versus 46 IU/l before"/>
  <result pre="recursive two-stage group sequential randomized controlled trialTrials21January (1)2020831900204 ChenZ.HuJ.ZhangZ.JiangS.HanS.YanD.Efficacy of" exact="hydroxychloroquine" post="in patients with COVID-19: results of a randomized clinical"/>
  <result pre="17, 20202020Available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2. [Cited 22 June 2020]. MarGautretP.LagierJ.-C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
  <result pre="inhibits both epidemic and zoonotic coronavirusesSci Transl Med93962017 WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 </snippets>
</snippetsTree>
